Lucio Rovati
Chief Executive Officer presso Rottapharm Biotech SRL
Profilo
Lucio Rovati is the founder of Rottapharm Biotech SRL, which was founded in 2014.
He holds the title of Chief Executive Officer & Chief Scientific Officer at Rottapharm Biotech SRL.
Dr. Rovati is currently working as Deputy Vice Chairman & Chief Scientific Officer at Rottapharm SpA since 1985.
He is also a Director at Olatec Therapeutics LLC, a Partner at Fidim Srl, and an Advisor at Panakes Partners SGR SpA.
Dr. Rovati previously worked as a Director at Assobiotec.
He obtained a doctorate degree from the University of Milan.
Posizioni attive di Lucio Rovati
Società | Posizione | Inizio |
---|---|---|
Fidim Srl
Fidim Srl Financial ConglomeratesFinance Fidim Srl operates as a holding company. The company is headquartered in Monza, Italy. | Corporate Officer/Principal | - |
Rottapharm SpA
Rottapharm SpA Pharmaceuticals: MajorHealth Technology Rottapharm SpA engages in the research, development, manufacture, and marketing of pharmaceuticals and products for wellness and personal care. Its products are distributed through the following categories: Semi-ethical, which includes prescribed and non-reimbursed, non-reimbursed, and over-the-counter medicines, cosmetics, nutraceuticals, and medical equipment; Reimbursed pharmaceuticals; and Natural extracts, which carry the brand Euromed. The company was founded by Luigi Rovati in 1961 and is headquartered in Milan, Italy. | Chief Tech/Sci/R&D Officer | 01/01/2008 |
Olatec Therapeutics LLC
Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Director/Board Member | - |
Rottapharm Biotech SRL
Rottapharm Biotech SRL BiotechnologyHealth Technology Rottapharm Biotech SRL operates as a drug research and development company. The company was founded in 1961 and is headquartered in Monza, Italy. | Chief Executive Officer | 01/01/2014 |
Panakes Partners SGR SpA
Panakes Partners SGR SpA Investment ManagersFinance Panakes Partners Sgr SpA (Panakes Partners) is a venture capital firm founded in 2015 by Alessio Beverina, Fabrizio Landi and Diana Sareceni. The firm is headquartered in Milan, Italy. | Consultant / Advisor | - |
Precedenti posizioni note di Lucio Rovati
Società | Posizione | Fine |
---|---|---|
Assobiotec
Assobiotec Miscellaneous Commercial ServicesCommercial Services Assobiotec is an organization that represents approximately 130 companies and technological and scientific parks in the biotech sector. Assobiotec is based in Milan, Italy. The Italian company focuses on various areas such as health, agriculture, environment, and industrial processes. The private company was founded in 1986, and the CEO is Leonardo Vingiani. | Director/Board Member | - |
Formazione di Lucio Rovati
University of Milan | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 6 |
---|---|
Rottapharm SpA
Rottapharm SpA Pharmaceuticals: MajorHealth Technology Rottapharm SpA engages in the research, development, manufacture, and marketing of pharmaceuticals and products for wellness and personal care. Its products are distributed through the following categories: Semi-ethical, which includes prescribed and non-reimbursed, non-reimbursed, and over-the-counter medicines, cosmetics, nutraceuticals, and medical equipment; Reimbursed pharmaceuticals; and Natural extracts, which carry the brand Euromed. The company was founded by Luigi Rovati in 1961 and is headquartered in Milan, Italy. | Health Technology |
Fidim Srl
Fidim Srl Financial ConglomeratesFinance Fidim Srl operates as a holding company. The company is headquartered in Monza, Italy. | Finance |
Assobiotec
Assobiotec Miscellaneous Commercial ServicesCommercial Services Assobiotec is an organization that represents approximately 130 companies and technological and scientific parks in the biotech sector. Assobiotec is based in Milan, Italy. The Italian company focuses on various areas such as health, agriculture, environment, and industrial processes. The private company was founded in 1986, and the CEO is Leonardo Vingiani. | Commercial Services |
Panakes Partners SGR SpA
Panakes Partners SGR SpA Investment ManagersFinance Panakes Partners Sgr SpA (Panakes Partners) is a venture capital firm founded in 2015 by Alessio Beverina, Fabrizio Landi and Diana Sareceni. The firm is headquartered in Milan, Italy. | Finance |
Rottapharm Biotech SRL
Rottapharm Biotech SRL BiotechnologyHealth Technology Rottapharm Biotech SRL operates as a drug research and development company. The company was founded in 1961 and is headquartered in Monza, Italy. | Health Technology |
Olatec Therapeutics LLC
Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Lucio Rovati